Metacognitive Therapy for Anxiety Disorders: a Review of Recent Advances and Future Research Directions

[1] Bijl RV(1998)Prevalence of psychiatric disorder in the general population: results of the Netherlands mental health survey and incidence study (NEMESIS) Soc Psychiatry Psychiatr Epidemiol 33 587-595

[2] Ravelli A(2004)Prevalence, co-morbidity and correlates of mental disorders in the general population: results from the German health interview and examination survey (GHS) Psychol Med 34 597-611

[3] van Zessen G(2004)Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on alcohol and related conditions Arch Gen Psychiatry 61 807-816

[4] Jacobi F(2005)Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication Arch Gen Psychiatry 62 593-602

[5] Wittchen H-U(2011)Epidemiology of anxiety disorders in the Australian general population: findings of the 2007 Australian National Survey of mental health and wellbeing Aust N Z J Psychiatry 45 957-967

[6] Holting C(2010)The global burden of anxiety disorders in 2010 Psychol Med 44 2363-2374

[7] Grant BF(2009)Comorbidity in Australia: findings of the 2007 National Survey of mental health and wellbeing Aust N Z J Psychiatry 43 606-614

[8] Stinson FS(2015)Sex differences in the temporal sequencing of anxiety, mood and substance use disorders in the general population: findings from the 2007 Australian National Survey of mental health and wellbeing Epidemiol Psychiatr Sci 24 45-53

[9] Dawson DA(2000)Lifetime panic-depression comorbidity in the National Comorbidity Survey: association with symptoms, impairment, course and help-seeking Br J Psychiatry 176 229-235

[10] Chou SP(2001)Current and lifetime comorbidity of the DSM-IV anxiety and mood disorders in a large clinical sample J Abnorm Psychol 110 585-599

[1] Bijl RV(1998)Prevalence of psychiatric disorder in the general population: results of the Netherlands mental health survey and incidence study (NEMESIS) Soc Psychiatry Psychiatr Epidemiol 33 587-595

[2] Ravelli A(2004)Prevalence, co-morbidity and correlates of mental disorders in the general population: results from the German health interview and examination survey (GHS) Psychol Med 34 597-611

[3] van Zessen G(2004)Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on alcohol and related conditions Arch Gen Psychiatry 61 807-816

[4] Jacobi F(2005)Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication Arch Gen Psychiatry 62 593-602

[5] Wittchen H-U(2011)Epidemiology of anxiety disorders in the Australian general population: findings of the 2007 Australian National Survey of mental health and wellbeing Aust N Z J Psychiatry 45 957-967

[6] Holting C(2010)The global burden of anxiety disorders in 2010 Psychol Med 44 2363-2374

[7] Grant BF(2009)Comorbidity in Australia: findings of the 2007 National Survey of mental health and wellbeing Aust N Z J Psychiatry 43 606-614

[8] Stinson FS(2015)Sex differences in the temporal sequencing of anxiety, mood and substance use disorders in the general population: findings from the 2007 Australian National Survey of mental health and wellbeing Epidemiol Psychiatr Sci 24 45-53

[9] Dawson DA(2000)Lifetime panic-depression comorbidity in the National Comorbidity Survey: association with symptoms, impairment, course and help-seeking Br J Psychiatry 176 229-235

[10] Chou SP(2001)Current and lifetime comorbidity of the DSM-IV anxiety and mood disorders in a large clinical sample J Abnorm Psychol 110 585-599